The expression of glucose regulated protein-94 in colorectal carcinoma cells treated by sodium butyrate

Cell Res. 2000 Jun;10(2):115-25. doi: 10.1038/sj.cr.7290041.

Abstract

The expression of glucose regulated protein 94 (GRP94) during the treatment of human colorectal carcinoma cell line-Clone A cells with sodium butyrate was studied. Sodium butyrate (SB) can cause functional and morphological effects on Clone A cells including growth arrest at G0/G1 stage and cell differentiation as observed by morphological changes, MTT and flow cytometry assays, as well as reduced Grp94 gene expression as shown by Northern blot and Western blot assays. The possible mechanism of the correlation between Grp94 gene expression and tumor growth inhibition and cell differentiation is briefly discussed.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Butyrates / pharmacology*
  • Cell Survival / drug effects
  • Colorectal Neoplasms
  • Gene Expression / drug effects
  • Glucose / metabolism*
  • Growth Inhibitors / pharmacology*
  • HSP70 Heat-Shock Proteins / biosynthesis
  • HSP70 Heat-Shock Proteins / genetics*
  • Humans
  • Membrane Proteins / biosynthesis
  • Membrane Proteins / genetics*
  • Molecular Chaperones / biosynthesis
  • Molecular Chaperones / genetics*
  • Sodium
  • Tumor Cells, Cultured

Substances

  • Butyrates
  • Growth Inhibitors
  • HSP70 Heat-Shock Proteins
  • Membrane Proteins
  • Molecular Chaperones
  • glucose-regulated proteins
  • Sodium
  • Glucose